Physician profile
William Yang
NPI 1811359011
$984.51
in general payments reported to CMS, 2019-2025
13 companies · $24.79 in 2025
The $24.79 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $232 · 2022: $88.24 · 2023: $417 · 2024: $222 · 2025: $24.79.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $416 · Education: $248.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $416.12 |
| Education | $247.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $247.98 | 2023 | Ensite Precision, Ensite |
| Abiomed | $169.23 | 2023 | Impella |
| Medtronic, INC. | $118.03 | 2024 | Symplicity G3 |
| Boston Scientific Corporation | $112.02 | 2021 | |
| W. L. Gore & Associates, INC. | $91.25 | 2021-2022 | |
| Irhythm Technologies, INC. | $80.00 | 2024 | Zio Xt Patch, Zio Monitor |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $40.22 | 2021 | |
| Viiv Healthcare Company | $24.79 | 2025 | Rukobia |
| Progenics Pharmaceuticals, INC. | $24.07 | 2024 | |
| Janssen Pharmaceuticals, INC | $22.25 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $21.89 | 2021 | |
| Biotronik INC. | $16.46 | 2022 | |
| Pfizer INC. | $16.32 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Yang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.